Edgewise Therapeutics (EWTX) announced positive updates from the ongoing CIRRUS-HCM, Phase 2 clinical trial of EDG-7500, a novel oral, selective, ...
Coffee and the caffeine in it were long-considered a risk for patients with certain heart conditions. But a recent study ...
The area addressed is vast—a single Medline search with the term “molecular mechanisms atrial fibrillation” revealed 611 papers. We have therefore chosen to focus on clinically relevant mechanisms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback